The nearly $1 billion won by VirnetX in patent trials against Apple Inc. exists under a cloud since the Patent Trial and Appeal Board has found the patents invalid. With appeals pending from the board's decisions and one of the trials, here's a look at VirnetX's arguments that the patents shouldn't have been reviewed, and Apple's efforts to flip the verdict.
After a number of long, drawn-out patent battles, Synopsys Inc. and Magma Design Automation have made peace, with Magma agreeing to pay $12.5 million and the companies agreeing to a cross-licensing deal.
Four high school students have filed a lawsuit against an anti-plagiarism service, accusing the company of violating copyright laws by archiving student papers and works.
In a surprise victory for Merck & Co., the European Patent Office reinstated Wednesday the drug maker's critical patent for its osteoporosis drug Fosamax Once Weekly, nearly three years after it was first declared invalid.
In a move that could mark the resolution of a patent infringement suit over hip implant technology that has lasted almost five years, a court has granted summary judgment to a subsidiary of orthopedics company Stryker Corp.
The Federal Circuit upheld a Merck & Co. Inc. patent Thursday which will keep a generic version of hypertension drug Trusopt off the market until the patent expires next year.
A federal jury has awarded $12.5 million to Diomed Holdings Inc., which had accused AngioDynamics Inc. and Vascular Solutions Inc. of infringing its patent for the endovascular laser treatment of varicose veins.
In the latest legal feud over a blockbuster cholesterol drug, Schering-Plough Corp. has hauled Glenmark Pharmaceuticals to court on allegations that the Indian generics maker has infringed a patent covering its anti-cholesterol treatment Zetia.
A U.K. appeals court has affirmed that Dan Brown’s blockbuster book “The Da Vinci Code” did not plagiarize the work of two historians, despite some similarities.
Counsel for a litigious patent-holding company has lost a bid for a stay on sanctions imposed by a court in its failed infringement claim against a mortgage lender.
A federal judge has thrown out a number of claims against Walt Disney Co. brought by the family that has the merchandising rights to the “Winnie the Pooh” trademark.
Though the European Central Bank won its patent noninfringement case against U.S.-based anti-counterfeiting technology maker Document Security Systems Inc. in the British High Court on Monday, a subsequent loss in the German Patent Court showed DSS still giving the bank a run for its money.
Computer giant Hewlett-Packard Co. has filed a patent infringement lawsuit against Taiwanese rival Acer Inc., accusing the smaller company of infringing five patents for a variety of personal computer functions.
A federal judge has granted summary judgment to a number of department stores, ending a lawsuit that alleged they were infringing on a patent relating to technology for establishing credit accounts.
After surviving summary judgment, Forgent Networks Inc. is barreling closer to facing off with its opponents in front of a jury as the battle over a highly litigated patent for video playback technology prepares to take center stage.
Tyco Healthcare Group LP has filed a lawsuit against a subsidiary of Pharmaceutical Holdings Corp., alleging it infringed four patents for Restoril by seeking approval to make a generic version of the sleep aid.
Signaling a possible end to the long-running Napster litigation, Bertelsmann AG has reached a settlement with the last major record label that had sued the German media giant in connection to its financial backing of the infamous file-sharing service.
Pillsbury Winthrop Shaw Pittman has nabbed intellectual property practitioner Fred Grasso from boutique firm Kenyon & Kenyon to join its Northern Virginia office as of counsel, the firm said Tuesday.
A district court has banned the federal drug agency from granting new applications by generic drug makers to market cheap copies of Pfizer’s popular Norvasc until it hears Mylan Laboratories case for six months’ exclusivity.
Critics of legislation that would provide a pathway for copies of biologic drugs to make their way to the marketplace say the proposal allows no market exclusivity and unfairly tilts the advantage during patent litigation to generics manufacturers.
The European Parliament is one step closer to a vote on harmonizing criminal sanctions for certain copyright infringements after the body’s legal affairs committee gave the green light to a draft version of a controversial IP directive.